基本信息
views: 9
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Clara Maria AUSIELLO: C U R R I C U L U M V I T A E
Education
1975 Degree with full score in Biological Science, Rome University.
1979 PhD with full score in Medical Genetics, Rome University.
Postdoctoral EXPERIENCE AND fellowships
1979 Research Fellow Basel Institute for Immunology, Switzerland.
1980 Research Fellow Department of Microbiology, Aarus University, Denmark.
1975-1997 Guest Fellow, Laboratory of Bacteriology and Medical Microbiology, Istituto Superiore di Sanitá, Roma.
position held
1982-1997 Researcher for the National Research Council (CNR) at the Institute for Tissue Typing and Problems linked with Dialysis, Rome.
1997 2007 Senior Researcher in the department of Infectious, Parasitic, and Immune-mediated Diseases (MIPI), Istituto Superiore di Sanità (ISS), Rome.
2007-2016 Researcher Director in the department of Infectious, Parasitic, and Immune-mediated Diseases, ISS, Rome.
2017 Volunteer exsternal collaborateur Komen-Italia onlus organization at the forefront in the fight against breast cancer.
Major Funding as Principal Applicant:
• CNR: Progetto Finalizzato Oncologia (1984 –1989). Natural Cytotoxic Activity against neoplastic cells.
• CNR: Progetto Finalizzato Applicazioni Cliniche alla Ricerca Oncologica (1992-1996). Local Immunotherapy in bladder and glioma tumors.
• NIAID-NIH-ISS: Cell Mediated Immune Response assessement in “Clinical Trial for the Efficacy of acellular pertussis vaccines" (1993-1999).
• CNR: Progetto Finalizzato Biotecnologie (1998 - 2001). Biological role of the Ectoenzyme CD38.
• Italian Health Ministry: Ricerca finalizzata 1998: “Citochine come adiuvanti nella preparazione di vaccini di nuova generazione.”
• Italian Health Ministry, Ricerca finalizzata 1999:”Approcci innovativi alla definizione di antigeni protettivi, adiuvanti e correlati di protezione per vaccini batterici, micotici e protozoarei”.
• Italian Health Ministry; Ricerca Corrente 2000: “ Metodi innovativi per la valutazione della qualità dei vaccini anti-infettivi”.
• Italian Health Ministry: Progetto Strategico 2001: “Approcci immuno-terapeutici innovativi nella lotta alle infezioni opportuniste”
• Italian Health Ministry: Ricerca finalizzata 2002:”Vaccini anti-infettivi per l’uomo nel terzo millennio: integrazione di approcci molecolari, microbiologici ed immunologici”.
• Italian Health Ministry: Ricerca finalizzata 2003:”Disregolazione del sistema immunitario: analisi dei meccanismi cellulari che intervengono nelle patologie autoimmuni e da allergia”.
• VI Programma Nazionale Ricerca sull’AIDS 2004: Prodotti microbici in grado di modulare le funzioni di cellule DC- l’ interazione con proteine virali di HIV-1 e i processi di infezione.
• Italian Health Ministry: Ricerca finalizzata 2005:” Infezioni croniche e mimetismo molecolare implicati nei processi autoimmuni dell’aterosclerosi: nuove strategie terapeutiche”.
• Italian Health Ministry: Ricerca finalizzata 2006 - coordinator of the project: “Individuazione di bersagli e strategie terapeutiche per patologie croniche ed immunodisregolative ad alta prevalenza”. Principal Investigato of a UO: Modulazione dell'asse citochinico IL-23/IL-17 in patologie infiammatorie croniche e autoimmuni.
• Principal Investigator within the European Community Founded Project 2008-2011 ChildINNOVAC: " European Network on Nasal Vacccination against Respiratory Infections in young children ". Life Sciences 7° program 2007-2013.
PrincipaL ISS Service DUITY
• Expert on anti-infectious vaccines.
• ECDC Laboratoty Contact Person for pertussis surveillance:
Ad hoc consultant:
• Italian Foreign affair Ministry: Expert Immunologist in Support Program to Kenya National Program against AIDS. 1990
• WHO: Informal consultation with manufacturers and WHO Working Group on Mouse Protection Models for acellular pertussis containing vaccines. NIBSC, Potters Bar, UK. 1998.
• WHO: Working Group on the Standardization and Control of pertussis Vaccines. Ferney-Voltaire, France. 2003.
• WHO: Informal Consultation on the Standardization and Control of Pertussis Vaccine. Geneva. 2005
PEER-REVIEW ACTIVITY FOR INTERNATIONAL PROGRAMS/PROJECTS
• Expert evaluator of European Community project “Quality of life management of living resources” –“Control of infectious diseases” 5° FW program. 2000
• Expert evaluator of European Community project “Marie Curie Fellowships”, Life Sciences 5° and 6° FW program 2001-2006.
• Expert evaluator of European Community project “People: Marie Curie Fellowships”, Life Sciences 7° program 2007-2013.
• Expert evaluator of European Community project “Infrastructures”, Life Sciences 7° program 2007-2013.
• expert evaluator of European Community project Marie Skłodowska-Curie Individual Fellowships and ITN H2020
• Expert evaluator - Evaluation Committee “Immunology and Infection” of the French National Research Agency
• Expert evaluator - National Education and Scientific Research and its Executive Agency for Higher Education, Research,
Research Interests
Papers共 45 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PERTUSSIS INFECTION AND VACCINES: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 12 (2019): V-VI
Cited0Views0Bibtex
0
0
Cited33Views0WOSBibtex
33
0
Pathogens and Diseaseno. 7 (2015): ftv051-ftv051
semanticscholar(2015)
Cited0Views0Bibtex
0
0
Pathogens and Diseaseno. 7 (2015)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn